{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:26:04Z","timestamp":1790940364262,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.bcp.2008.07.024","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T15:41:05Z","timestamp":1217259665000},"page":"929-937","source":"Crossref","is-referenced-by-count":25,"title":["Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers"],"prefix":"10.1016","volume":"76","author":[{"given":"Joshua E.","family":"Muscat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Stellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John P.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2008.07.024_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1078-1439(03)00139-X","article-title":"Gender, racial and age differences in bladder cancer incidence and mortality","volume":"22","author":"Madeb","year":"2004","journal-title":"Urologic Oncology"},{"key":"10.1016\/j.bcp.2008.07.024_bib2","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0022-5347(05)64272-3","article-title":"Racial variation in the incidence of squamous cell carcinoma of the bladder in the United States","volume":"168","author":"Porter","year":"2002","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.bcp.2008.07.024_bib3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/jnci\/93.7.538","article-title":"Gender- and smoking-related bladder cancer risk","volume":"93","author":"Castelao","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.bcp.2008.07.024_bib4","unstructured":"IARC. IAfRoC. Tobacco Smoking. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Lyon: IARC; 1986. p. 270."},{"key":"10.1016\/j.bcp.2008.07.024_bib5","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1073\/pnas.86.20.7696","article-title":"Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines","volume":"86","author":"Butler","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bcp.2008.07.024_bib6","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/jnci\/86.9.712","article-title":"Acetylator phenotype, aminobiphenyl\u2013hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California","volume":"86","author":"Yu","year":"1994","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.bcp.2008.07.024_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/1098-2280(2000)36:3<221::AID-EM5>3.0.CO;2-Q","article-title":"N-acetyl transferase-2 and bladder cancer risk: a meta-analysis","volume":"36","author":"Johns","year":"2000","journal-title":"Environmental and Molecular Mutagenesis"},{"key":"10.1016\/j.bcp.2008.07.024_bib9","first-page":"503","article-title":"The use of caffeine for enzyme assays: a critical appraisal","volume":"53","author":"Kalow","year":"1993","journal-title":"Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00008571-200208000-00008","article-title":"The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors","volume":"12","author":"Rasmussen","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a022352","article-title":"Genetic polymorphism in the 5\u2032-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans","volume":"125","author":"Nakajima","year":"1999","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.bcp.2008.07.024_bib12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","article-title":"Functional significance of a C\u2192A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine","volume":"47","author":"Sachse","year":"1999","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00008571-199906000-00012","article-title":"Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: lack of a polymorphism in CYP1A2 in Caucasians","volume":"9","author":"Welfare","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002280050394","article-title":"A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers","volume":"53","author":"Schrenk","year":"1998","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib15","first-page":"131","article-title":"Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test","volume":"9","author":"Tantcheva-Poor","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/clpt.1992.203","article-title":"Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities","volume":"52","author":"Relling","year":"1992","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.bcp.2008.07.024_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01059025","article-title":"Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models","volume":"17","author":"Driscoll","year":"1989","journal-title":"Journal of Pharmacokinetics and Biopharmaceutics"},{"key":"10.1016\/j.bcp.2008.07.024_bib18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0022-3565(24)39177-3","article-title":"CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences","volume":"294","author":"Johnson","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bcp.2008.07.024_bib19","doi-asserted-by":"crossref","first-page":"S788","DOI":"10.1111\/j.1365-2125.2004.02297.x","article-title":"A simple test for acetylator phenotype using caffeine 1984","volume":"58","author":"Grant","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00008571-199206000-00003","article-title":"Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites","volume":"2","author":"Butler","year":"1992","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/aje\/kwm167","article-title":"Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis","volume":"166","author":"Sanderson","year":"2007","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.bcp.2008.07.024_bib22","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/carcin\/14.8.1689","article-title":"Genotype\/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans","volume":"14","author":"Bell","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2008.07.024_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0031-6997(25)06816-4","article-title":"N-acetylation pharmacogenetics","volume":"37","author":"Weber","year":"1985","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.bcp.2008.07.024_bib24","first-page":"449","article-title":"Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies?","volume":"5","author":"Le Marchand","year":"1996","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib25","first-page":"311","article-title":"Comparison of isoniazid phenotyping of black and white patients with emphasis on South African blacks","volume":"17","author":"Eidus","year":"1979","journal-title":"International Journal of Clinical Pharmacology and Biopharmacy"},{"key":"10.1016\/j.bcp.2008.07.024_bib26","first-page":"1132","article-title":"Isoniazid acetylator status of Black South African tuberculosis patients","volume":"50","author":"Bach","year":"1976","journal-title":"South African Medical Journal Suid-Afrikaanse tydskrif vir geneeskunde"},{"key":"10.1016\/j.bcp.2008.07.024_bib27","first-page":"491","article-title":"Ethnic differences in reactions to drugs and xenobiotics therapy","volume":"214","author":"Evans","year":"1986","journal-title":"Progress in Clinical and Biological Research"},{"key":"10.1016\/j.bcp.2008.07.024_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1126\/science.145.3630.391","article-title":"Genetics of isoniazid metabolism in Caucasian Negro, and Japanese Populations","volume":"145","author":"Dufour","year":"1964","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bcp.2008.07.024_bib29","first-page":"807","article-title":"Xenobiotic metabolism in idiopathic Parkinson's disease in Nigerian Africans","volume":"70","author":"Igbokwe","year":"1993","journal-title":"East African Medical Journal"},{"key":"10.1016\/j.bcp.2008.07.024_bib30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/BF00484527","article-title":"Acetylation of sulfamethazine in a Nigerian population","volume":"16","author":"Eze","year":"1978","journal-title":"Biochemical Genetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03190128","article-title":"Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria)","volume":"15","author":"Jeyakumar","year":"1990","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02657055","article-title":"N-acetylation in healthy and diseased children","volume":"39","author":"Hadasova","year":"1990","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00558506","article-title":"Acetylator polymorphism in Parkinson's disease","volume":"37","author":"Ladero","year":"1989","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib34","first-page":"281","article-title":"Acetylator polymorphism in Alzheimer's disease","volume":"2","author":"Ladero","year":"1993","journal-title":"The European Journal of Medicine"},{"key":"10.1016\/j.bcp.2008.07.024_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00315397","article-title":"Acetylator polymorphism in rheumatoid arthritis","volume":"45","author":"Ladero","year":"1993","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0361-090X(02)00010-7","article-title":"Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention","volume":"26","author":"Loktionov","year":"2002","journal-title":"Cancer Detection and Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib37","series-title":"Mutation and the environment. Part B. Metabolism testing methods and chromosomes","first-page":"7","article-title":"Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites","author":"Kadlubar","year":"1990"},{"key":"10.1016\/j.bcp.2008.07.024_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2125.1984.tb02372.x","article-title":"A simple test for acetylator phenotype using caffeine","volume":"17","author":"Grant","year":"1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/clpt.1991.176","article-title":"Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities","volume":"50","author":"Kalow","year":"1991","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"June","key":"10.1016\/j.bcp.2008.07.024_bib40","article-title":"Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer","author":"Yuan","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2008.07.024_bib41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(05)67137-1","article-title":"NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses","volume":"366","author":"Garcia-Closas","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2008.07.024_bib42","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/85.14.1159","article-title":"Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer","volume":"85","author":"Bell","year":"1993","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.bcp.2008.07.024_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/aje\/kwf018","article-title":"Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review","volume":"156","author":"Engel","year":"2002","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.bcp.2008.07.024_bib44","first-page":"861","article-title":"Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers","volume":"4","author":"Yu","year":"1995","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib45","first-page":"93","article-title":"Cholesterol screening in a community health promotion program: epidemiologic results from a biracial population","volume":"109","author":"Muscat","year":"1994","journal-title":"Public Health Reports"},{"key":"10.1016\/j.bcp.2008.07.024_bib46","first-page":"783","article-title":"Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers","volume":"6","author":"Richie","year":"1997","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib47","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0895-4356(90)90099-B","article-title":"Validation of a self-administered diet history questionnaire using multiple diet records","volume":"43","author":"Block","year":"1990","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.bcp.2008.07.024_bib48","first-page":"33","article-title":"Aromatic and hetrocyclic amine metabolism and phenotyping in humans","volume":"372","author":"Lang","year":"1991","journal-title":"Progress in Clinical and Biological Research"},{"key":"10.1016\/j.bcp.2008.07.024_bib49","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1124\/dmd.105.004796","article-title":"CYP2A6 is a principal enzyme involved in the hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans","volume":"33","author":"Kimura","year":"2005","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.bcp.2008.07.024_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00008571-200003000-00004","article-title":"Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians","volume":"10","author":"Park","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib51","first-page":"1974","article-title":"Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma","volume":"56","author":"Yengi","year":"1996","journal-title":"Cancer Research"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2008.07.024_bib52","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1007\/BF02439747","article-title":"Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma","volume":"254","author":"Jahnke","year":"1997","journal-title":"European Archives of Otorhinolaryngology"},{"key":"10.1016\/j.bcp.2008.07.024_bib53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ijc.20114","article-title":"Association of metabolic gene polymorphisms with tobacco consumption in healthy controls","volume":"110","author":"Smits","year":"2004","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.bcp.2008.07.024_bib54","first-page":"371","article-title":"Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk","volume":"7","author":"Millikan","year":"1998","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/j.1552-4604.1997.tb04765.x","article-title":"Acetylator phenotype in relation to age and gender in the Baltimore Longitudinal Study of Aging","volume":"37","author":"Korrapati","year":"1997","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2125.1987.tb03105.x","article-title":"Influence of age, sex and body weight on the dapsone acetylation phenotype","volume":"23","author":"Philip","year":"1987","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bcp.2008.07.024_bib57","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/BF03190002","article-title":"Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe","volume":"23","author":"Asprodini","year":"1998","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib58","first-page":"413","article-title":"Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene","volume":"3","author":"Nakajima","year":"1994","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib59","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.clpt.2004.08.021","article-title":"Bioequivalence revisited: influence of age and sex on CYP enzymes","volume":"76","author":"Bebia","year":"2004","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.bcp.2008.07.024_bib60","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/carcin\/21.6.1157","article-title":"Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets","volume":"21","author":"Lampe","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2008.07.024_bib61","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1158\/0008-5472.CAN-07-5009","article-title":"Inhibition of urinary bladder carcinogenesis by broccoli sprouts","volume":"68","author":"Munday","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/j.bcp.2008.07.024_bib62","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/carcin\/13.9.1561","article-title":"Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine","volume":"13","author":"Vistisen","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2008.07.024_bib63","first-page":"635","article-title":"Absence of the glutathione S-transferase M1 gene increases cytochrome P4501A2 activity among frequent consumers of cruciferous vegetables in a Caucasian population","volume":"7","author":"Probst-Hensch","year":"1998","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.toxlet.2003.10.029","article-title":"Acute cadimium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2","volume":"148","author":"Abu-Bakar","year":"2004","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.bcp.2008.07.024_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/tx990189w","article-title":"Inhibition of human cytochorme P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane","author":"Langouet","year":"2000","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.bcp.2008.07.024_bib66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/abbi.2000.1835","article-title":"Inhibition selectivity of grapefruit juice components on human cytochromes P450","volume":"378","author":"Tassaneeyakul","year":"2000","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.bcp.2008.07.024_bib67","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jnci\/96.7.506-a","article-title":"Stat bite: trends in cigarette smoking among adults, 1965\u20132001","volume":"96","year":"2004","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.bcp.2008.07.024_bib68","first-page":"571","article-title":"The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure","volume":"7","author":"Dallinga","year":"1998","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib69","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/1097-0142(19901215)66:12<2673::AID-CNCR2820661235>3.0.CO;2-G","article-title":"Cancer of the urinary bladder in blacks and whites. A case\u2013control study","volume":"66","author":"Harris","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2008.07.024_bib70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00054297","article-title":"Risk of urinary bladder cancer among blacks and whites: the role of cigarette use and occupation","volume":"2","author":"Burns","year":"1991","journal-title":"Cancer Causes & Control"},{"key":"10.1016\/j.bcp.2008.07.024_bib71","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00051343","article-title":"Smoking and bladder cancer risk in blacks and whites in the United States","volume":"4","author":"Hartge","year":"1993","journal-title":"Cancer Causes & Control"},{"key":"10.1016\/j.bcp.2008.07.024_bib72","first-page":"693","article-title":"Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl\u2013hemoglobin adduct levels","volume":"5","author":"Landi","year":"1996","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.bcp.2008.07.024_bib73","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00008571-200107000-00003","article-title":"Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1. NAT1 and NAT2","volume":"11","author":"Godschalk","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2008.07.024_bib74","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/jnci\/82.23.1826","article-title":"Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers","volume":"82","author":"Bartsch","year":"1990","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.bcp.2008.07.024_bib75","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/carcin\/23.5.861","article-title":"Determinants of 4-aminobiphenyl\u2013DNA adducts in bladder cancer biopsies","volume":"23","author":"Airoldi","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2008.07.024_bib76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00008571-200003000-00003","article-title":"NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case\u2013control studies conducted in the general population","volume":"10","author":"Marcus","year":"2000","journal-title":"Pharmacogenetics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295208005133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295208005133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T05:58:51Z","timestamp":1738303131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295208005133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0006295208005133"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2008.07.024","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}